Clinical Trial Update: Hypoxic Red Blood Cells for Burns and Hematological Malignancies at Haukeland University Hospital

View source ↗

Summary

A completed clinical trial at Haukeland University Hospital evaluated hypoxic red blood cells for burns and hematologic neoplasms; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burns
• Hematologic Neoplasms

Drugs mentioned

• Hypoxic Red Blood Cells

Snippet

Sponsor: Hemanext | Conditions: Hematologic Neoplasms, Burns | Status: COMPLETED | Results posted: 2025-05-18